REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH)

1 filings reported holding RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share as of Q4 2023.
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 10.4K shares of 101M outstanding shares and own 0.01% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.76M shares), VANGUARD GROUP INC (975K shares), MILLENNIUM MANAGEMENT LLC (802K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (206K shares), Rosalind Advisors, Inc. (196K shares), GEODE CAPITAL MANAGEMENT, LLC (179K shares), Polar Asset Management Partners Inc. (155K shares), EMC Capital Management (124K shares), Colony Group, LLC (121K shares), and Woodline Partners LP (120K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.